IMPORTANT MESSAGE
Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Development of a Novel Blinding Methodology for a Market Leading DPI
Development of a Novel Blinding Methodology for a Market Leading DPI
Innovation is one of Almac’s core values. Our unique inhaler blinding services provide a perfect illustration of this. While Almac has already developed and validated blinding techniques for most leading inhalers, continued launches of new inhalers mean we consistently face new challenges in this specialised area of clinical trial supplies.
